SCHEMBL21916268

SCHEMBL21916268

COc1cc(OCC2=CCCC=C2)ccc1-c1csc(CN)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 5/20 0.44
▸ CYP1B1 Q16678 5/20 0.44
▸ NPC1 O15118 4/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ MAPT P10636 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ NFKB1 P19838 2/20 0.41
▸ NFKB2 Q00653 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ RELA Q04206 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ ATM Q13315 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ DCK P27707 1/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ CYP2E1 P05181 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17384532 0.72 CYSLTR1 (0.38) RAB9AMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL2097189 0.70 CYP1A1 (0.68) CYP1A1CYP1B1NPC1RAB9AMAPT
SCHEMBL2097185 0.68 CYP1A1 (0.64) CYP1A1CYP1B1NPC1RAB9AMAPT
SCHEMBL21916989 0.68 HDAC3 (0.38) CYP1A1CYP1B1NPC1RAB9AMAPT
SCHEMBL15477792 0.68 CYP1A1 (0.68) CYP1A1CYP1B1NPC1RAB9AMAPT
SCHEMBL19787478 0.65 MAOB (0.47) —
SCHEMBL30557661 0.64 CYP1A1 (0.75) CYP1A1CYP1B1NPC1RAB9AMAPT
SCHEMBL1821573 0.64 CYP1A1 (0.75) CYP1A1CYP1B1NPC1RAB9AMAPT
SCHEMBL14765472 0.64 PPARD (0.56) CYP1A1CYP1B1NPC1RAB9AMAPT
SCHEMBL23743244 0.63 CYP1A1 (1.00) CYP1A1CYP1B1NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3628672-A1 INDANE DERIVATIVES FOR USE IN THE TREATMENT OF BACTERIAL INFECTION Antabio SAS (FR) 2020-04-01 — — EP disclosed
Send feedback